Predictors of mood response to acute tryptophan depletion: A reanalysis

Neuropsychopharmacology

Volumn 27, Issue 5, 2002, Pages 852-861

  Booij, Linda ^a   Van der Does, Willem ^a   Benkelfat, Chawki ^b   Bremner, J Douglas ^c   Cowen, Philip J ^d   Fava, Maurizio ^e   Gillin, Christian ^f   Leyton, Marco ^b   Moore, Polly ^f   Smith, Katharine A ^d   Van der Kloot, Willem A ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b MCGILL UNIVERSITY   (Canada)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e HARVARD MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Amino acids; Depression; Hamilton Depression Rating Scale; Mood; Serotonin; Tryptophan depletion

Indexed keywords

SEROTONIN UPTAKE INHIBITOR; TRYPTOPHAN;

ADULT; AMINO ACID ANALYSIS; ARTICLE; BIOCHEMISTRY; CHRONICITY; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DRUG EXPOSURE; DRUG MECHANISM; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD; PREDICTION; PRIORITY JOURNAL; REMISSION; SCORING SYSTEM; SEROTONINERGIC SYSTEM; SUICIDE; SUICIDE ATTEMPT;

ADULT; AFFECT; DEPRESSIVE DISORDER; FEMALE; FORECASTING; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; REGRESSION ANALYSIS; SEROTONIN UPTAKE INHIBITORS; SEX FACTORS; TRYPTOPHAN;

EID: 0036850587     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(02)00361-5     Document Type: Article

References (44)

1. Agren H., Mefford I.N., Rudorfer M.V., Linnoila M., Potter W.Z. Interacting neurotransmitter systems. a non-experimental approach to the 5-HIAA-HVA correlation in human CSF Psychiatry Res. 20:1986;175-193.
2. Biver F., Lotstra F., Monclus M., Wikler D., Damhout P., Mendlewicz J. Sex difference in 5HT2 receptor in the living human brain. Neurosci Lett. 204:1996;25-28.
3. Bremner J.D., Innis R.B., Salomon R.M., Staib L.H., Ng C.K., Miller H.L., Bronen R.A., Krystal J.H., Duncan J., Rich D., Price L.H., Malison R., Dey H., Soufer R., Charney D.S. Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse. Arch Gen Psychiatry. 54:1997;364-374.
4. Cleare A.J., Bond A.J. The effect of tryptophan depletion and enhancement on subjective and behavioral aggression in normal male subjects. Psychopharmacology (Berl). 118:1995;72-81.
5. Delgado P.L., Charney D.S., Price L.H., Aghajanian G.K., Landis H., Henninger G.R. Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry. 47:1990;411-418.
6. Delgado P.L., Price L.H., Miller H.L., Salomon R.M., Licinio J., Krystal J.H., Heninger G.R., Charney D.S. Rapid serotonin depletion as a provocative challenge test for patients with major depression. relevance to antidepressant action and the neurobiology of depression Psychopharm Bull. 27:1991;321-330.
7. Delgado P.L., Miller H.L., Salomon R.M., Licinio J., Krystal J.H., Moreno F.A., Heninger G.R., Charney D.S. Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine. Implications for the role of serotonin in the mechanism of antidepressant action Biol Psychiatry. 46:1999;212-220.
8. Ellenbogen M.A., Young S.N., Dean P., Palmour R.M., Benkelfat C. Mood response to acute tryptophan depletion in healthy volunteers. sex differences and temporal stability Neuropsychopharmacology. 15:1996;465-474.
9. Goodwin G.M., Murray C.L., Bancroft J. Oral d-fenfluramine and neuroendocrine challenge. problems with the 30 mg dose in men J Affec Disord. 30:1994;117-122.
10. Hamilton M. A rating scale for depression. Neurol Neurosurg Psychiatry. 23:1960;56-62.
11. Hays W.L. Statistics. 4th ed:1988;Holt, Rinehart, Winston, New York.
12. Joffe H., Cohen L.S. Estrogen, serotonin and mood disturbance. Where is the therapeutic bridge? Biol Psychiatry. 44:1998;798-811.
13. Keller M.B., Lavori P.W., Mueller T.I., Endicott J., Coryell W., Hirschfield R.M., Shes T. Time to recovery, chronicity, and levels of psychopathology in major depression, a 5-year prospective follow-up of 431 subjects. Arch Gen Psychiatry. 49:1992;809-816.
14. Kornstein S.G., Schatzberg A.F., Thase M.E., Yonkers K.A., McCullough J.P., Keitner G.I., Gelenberg A.J., Davis S.M., Harrison W.M., Keller M.B. Gender differences in treatment response to sertraline versus imipramine in chronic depression. Am J Psychiatry. 157:2000;1445-1452.
15. Krahn L.E., Lu P.Y., Klee G., Delgado P.R., Lin S.C., Zimmerman R.C. Examining serotonin function. a modified technique for rapid tryptophan depletion Neuropsychopharmacology. 15:1996;325-328.
16. LeMarquand D.G., Benkelfat C., Pihl R.O., Palmour R.M., Young S.N. Behavioral disinhibition induced by tryptophan depletion in nonalcoholic young men with multigenerational family histories of paternal alcoholism. Am J Psychiatry. 156:1999;1771-1779.
17. Leyton M., Young S.N., Benkelfat C. Relapse of depression after rapid depletion of tryptophan. Lancet. 349:1997;1840-1841. [letter].
18. Leyton M., Young S.N., Blier P., Ellenbogen M.A., Palmour R.M., Ghadirian A., Benkelfat C. The effect of tryptophan depletion on mood in medication-free, former patients with major affective disorder. Neuropsychopharmacology. 16:1997;294-297.
19. Leyton M., Ghadirian A.M., Young S.N., Palmour R.M., Blier P., Helmers K.F., Benkelfat C. Depressive relapse following acute tryptophan depletion in patients with major depressive disorder. J Psychopharmacol. 14:2000;294-297.
20. Moeller F.G., Dougherty D.M., Swann A.C., Collins D., Davis C.M., Cherek D.R. Tryptophan depletion and aggressive responding in healthy males. Psychopharmacology (Berl). 126:1996;97-103.
21. Moore P., Gillin J.C., Bhatti T., DeModena A., Seifritz E., Clark C., Stahl S., Rapaport M., Kelsoe J. Rapid tryptophan depletion, sleep, electroencephalogram, and mood in men with remitted depression on serotonin reuptake inhibitors. Arch Gen Psychiatry. 55:1998;534-539.
22. Moore P., Landolt H., Seifritz E., Clark C., Bhatti T., Kelsoe J., Rapaport M., Gillin J.C. Clinical and physiological consequences of rapid tryptophan depletion. Neuropsychopharmacology. 23:2000;601-622.
23. Moreno F.A., Heninger G.R., McGahuey C.A., Delgado P.L. Tryptophan depletion and risk of depression relapse. a prospective study of tryptophan depletion as a potential predictor of depressive episodes Biol Psychiatry. 48:2000;327-329.
24. Mueller T.I., Leon A.C., Keller M.B., Solomon D.A., Endicott J.E., Coryell W., Warshaw M., Maser J.D. Recurrence after recovery from major depressive disorder during 15 years of observational follow-up. Am J Psychiatry. 156:1999;1000-1006.
25. Murphy D.L., Mueller E.W., Hill J.L., Tolliver T.J., Jacobsen F.M. Comparative anxiogenic, neuroendocrine, and other physiologic effects of m-chlorophenylpiperazine given intravenously or orally to healthy volunteers. Psychopharmacology (Berl). 98:1989;275-282.
26. Neumeister A., Turner E.H., Matthews J.R., Postolache T.T., Barnett R.L., Rauh M., Vetticad R., Kasper S., Rosenthal N.E. Effects of tryptophan depletion vs. catecholamine depletion in patients with seasonal affective disorder in remission with light therapy. Arch Gen Psychiatry. 44:1998;524-530.
27. Nishizawa S., Benkelfat C., Young S.N., Leyton M., Mzengeza S., De Montigny C., Blier P., Diksic M. Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl Acad Sci USA. 94:1997;5308-5313.
28. Olkin I. Meta-analysis reconciling the results of independent studies. Statist Med. 14:1995;457-472.
29. O'Sullivan R.L., Fava M., Agustin C., Baer L., Rosenbaum J.F. Sensitivity of the six-item Hamilton Depression Rating Scale. Acta Psychiatr Scand. 95:1997;379-384.
30. Pihl R.O., Young S.N., Harden P., Plotnick S., Chamberlain B., Ervin F.R. Acute effect of altered tryptophan levels and alcohol on aggression in normal human males. Psychopharmacology (Berl). 119:1995;353-360.
31. Smith K.A., Fairburn C.G., Cowen P.J. Relapse of depression after rapid depletion of tryptophan. Lancet. 349:1997;915-919.
32. Smith K.A., Clifford E.M., Hockney R.A., Clark D.M., Cowen P.J. Effect of tryptophan depletion on mood in male and female volunteers. a pilot study Hum Neuropsychopharmacol. 12:1997;111-117.
33. Smith K.A., Fairburn C.G., Cowen P.J. Symptomatic relapse in bulimia nervosa following acute tryptophan depletion. Arch Gen Psychiatry. 56:1999;171-176.
34. Spillmann M.K., Van der Does A.J.W., Rankin M.A., Vuolo R.D., Alpert J.E., Nierenberg A.A., Rosenbaum J.F., Hayden D., Schoenfeld D., Fava M. Tryptophan depletion in SSRI-recovered depressed outpatients. Psychopharmacology (Berl). 155:2001;123-127.
35. Stevens J. Applied multivariate statistics for the social sciences. 3rd ed:1996;Lawrence Erlbaum, Hillsdale, NJ.
36. Stewart L.A., Parmar M.K. Meta-analysis of the literature or of individual data. is there a difference? Lancet. 341:1993;418-421.
37. Van der Does A.J.W. The effects of tryptophan depletion on mood and psychiatric symptoms. review J Affec Disord. 64:2001;107-119. a.
38. Van der Does A.J.W. The mood-lowering effect of tryptophan depletion. possible explanation for discrepant findings Arch Gen Psychiatry. 58:2001;200-201. b [letter].
39. Van Praag H.M. Serotonergic dysfunction and aggression control. Psychol Med. 21:1991;15-19.
40. Van Praag H.M. Faulty cortisol/serotonin interplay. Psychopathological and biological characterisation of a new, hypothetical depression subtype (SeCa depression). Psychiatry Res. 65:1996;153-157.
41. Weisberg S. Applied Linear Regression. 1985;Wiley, New York.
42. Weltzin T.E., Fernstrom M.H., Fernstrom J.D., Neuberger S.K., Kaye W.H. Acute tryptophan depletion and increased food intake and irritability in bulimia nervosa. Am J Psychiatry. 152:1995;1668-1671.
43. Wolf F.M. Meta-analysis. Quantitative methods for research synthesis. 1986;Sage University, Beverly Hills, CA.
44. Young S.N., Smith S.E., Pihl R.O., Ervin F.R. Tryptophan depletion causes a rapid lowering of mood in normal males. Psychopharmacology (Berl). 87:1985;173-177.